TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
St1 Biokraft Stockholm AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
94,928
|
79,936
|
92,731 |
Financial expenses |
23
|
0
|
377 |
Earnings before taxes |
27,533
|
15,639
|
18,596 |
EBITDA |
26,372
|
14,891
|
18,980 |
Total assets |
78,311
|
60,535
|
70,759 |
Current assets |
58,004
|
36,347
|
43,717 |
Current liabilities |
53,755
|
34,175
|
40,527 |
Equity capital |
24,556
|
26,360
|
30,232 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
31.4%
|
43.5%
|
42.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
29.0%
|
19.6%
|
20.1% |
Return on assets (ROA) |
35.2%
|
25.8%
|
26.8% |
Current ratio |
107.9%
|
106.4%
|
107.9% |
Return on equity (ROE) |
112.1%
|
59.3%
|
61.5% |
Change turnover |
14,581
|
-5,284
|
4,086 |
Change turnover % |
18%
|
-6%
|
5% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.